EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study

Mitra Nekouei Shahraki iD, Frank W G Leebeek iD, Moniek P M de Maat iD, Maryam Kavousi, Daniel Bos

European Journal of Haematology · 2026-12 · 117 (6) · 1637-1646

DOI: 10.1111/ejh.70309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 30.08.2026. Verfasst von Mitra Nekouei Shahraki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: ADAMTS13 Protein, von Willebrand Factor, Atherosclerosis. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dutch Heart Foundation (AtheroNeth consortium), Leducq Foundation (COMET Network), Fondation Leducq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Higher von Willebrand factor (VWF) levels and lower ADAMTS13 activity are linked to increased risk of atherosclerotic cardiovascular disease, but their association with atherosclerosis burden, a potential underlying mechanism, remains unclear. We investigated associations of these biomarkers with arterial calcification, a surrogate of atherosclerosis, in a general population.

Methods

In 2224 Rotterdam Study participants with measured VWF Antigen level (VWF:Ag) and ADAMTS13 activity (in percentage), computed tomography assessed calcification volume in the coronary arteries (CAC), aortic arch (AAC), and extracranial and intracranial carotid arteries (ECAC, ICAC) (mean age 69.5 ± 6.7 years; 51.5% female). Associations of VWF:Ag, ADAMTS13 activity, and their ratio (linear and quartiles) with calcification (linear and quartiles) were evaluated using multivariable linear and proportional odds logistic regression, adjusting for demographic and cardiovascular factors.

Results

Higher ADAMTS13 activity was significantly associated with lower volume of CAC ( β [95% CI]: −0.04 [−0.08, −0.01]), AAC (−0.08 [−0.11, −0.03]), and ECAC (−0.05 [−0.09, −0.01]), but not in ICAC. A higher ADAMTS13:VWF ratio showed stronger inverse associations, extending to ICAC, suggesting a potential interplay between ADAMTS13 and VWF ( β [95% CI]: CAC: −0.12 [−0.21, −0.02]; AAC: −0.20 [−0.30, −0.10]; ECAC: −0.08 [−0.18, −0.01]; ICAC: −0.11 [−0.21, −0.02]). The effect size of the ratio increased across quartiles at all artery‐specific locations, strengthening the observed relationship. Across levels of calcification, associations of the biomarkers remained generally unchanged.

Conclusions

Our findings support the potential relevance of ADAMTS13 activity in arterial calcification and, by extension, atherosclerosis. The observed associations may reflect both its balance with VWF and pathways independent of VWF. Future longitudinal and causal studies should determine whether ADAMTS13 influences the development and progression of arterial calcification through VWF‐dependent or VWF‐independent pathways, thereby clarifying its biological role and potentially identifying targets for preventive strategies against atherosclerotic vascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAMTS13 Proteinvon Willebrand FactorAtherosclerosisHumansFemaleAgedBiomarkersMaleNetherlandsMiddle AgedPopulation SurveillanceRisk Factors

Substanzen

ADAMTS13 Proteinvon Willebrand FactorBiomarkersADAMTS13 protein, human

Autor:innen und Institutionen

  • Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Department of Hematology, Erasmus University Medical Centre, Rotterdam, the Netherlands.
  • Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.

ORCID-Profile: Mitra Nekouei Shahraki, Frank W G Leebeek, Moniek P M de Maat

Förderung

  • Dutch Heart Foundation (AtheroNeth consortium)
  • Leducq Foundation (COMET Network)
  • Fondation Leducq

Zitieren

APA

Nekouei Shahraki, M., Leebeek, F. W. G., de Maat, M. P. M., Kavousi, M., & Bos, D. (2026). Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study. European Journal of Haematology, 117(6), 1637-1646. https://doi.org/10.1111/ejh.70309

Vancouver

Nekouei Shahraki M, Leebeek FWG, de Maat MPM, Kavousi M, Bos D. Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study. European Journal of Haematology. 2026;117(6):1637-1646. doi:10.1111/ejh.70309

BibTeX
@article{NekoueiShahraki2026,
  author = {Nekouei Shahraki, Mitra and Leebeek, Frank W G and de Maat, Moniek P M and Kavousi, Maryam and Bos, Daniel},
  title = {Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {117},
  number = {6},
  pages = {1637--1646},
  doi = {10.1111/ejh.70309}
}
Kostenlos starten →